H-AK^FVAAWTLK^AAA-OH

Ref. 3D-PP45512

Produktinformation

• Name: H-AK^FVAAWTLK^AAA-OH
• Synonyme: NH2-Ala-Lys^Phe-Val-Ala-Ala-Trp-Thr-Leu-Lys^Ala-Ala-Ala-OH

Beschreibung

Peptide H-AK^FVAAWTLK^AAA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AK^FVAAWTLK^AAA-OH include the following: Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1 Z Duan, J Guo, X Huang, H Liu, X Chen - Journal of Medical , 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.24167 An altered peptide ligand for naaca¯ve cytotoxic T lymphocyte epitope of TRP-2(180-188) enhanced immunogenicity Y Tang, Z Lin, B Ni, J Wei, J Han, H Wang - Cancer Immunology , 2007 - Springerhttps://link.springer.com/article/10.1007/s00262-006-0195-x Synthesis of multicomponent peptide-based vaccine candidates against group A streptococcus WM Hussein , J Xu, P Simerska - Australian Journal of , 2016 - CSIRO Publishinghttps://www.publish.csiro.au/ch/CH16501 A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo SH Tu, HI Huang , SI Lin, HY Liu, YP Sher - Journal of , 2012 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/FullText/2012/04000/A_Novel_HLA_A2_restricted_CTL_Epitope_of.4.aspx Improved immunogenicity against a Her2/neu-Derived peptide by employment of a Pan HLA DR-Binding epitope and CpG in a BALB/c mice model S Tahaghoghi-Hajghorbani - Anti-Cancer Agents , 2017 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/acamc/2017/00000017/00000006/art00010 Peptide-based vaccines RJ Nevagi , I Toth , M Skwarczynski - Peptide applications in biomedicine , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780081007365000120 Optimized anchor-modified peptides targeting mutated RAS are promising candidates for immunotherapy RB Baleeiro , LSC Dunmall, P Liu, S Lu , Y Lone - Frontiers in , 2022 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2022.902709/full A chimera containing CD4+ and CD8+ T-cell epitopes of the Leishmania donovani nucleoside hydrolase (NH36) optimizes cross-protection against MV Alves-Silva, D Nico , A Morrot, M Palatnik - Frontiers in , 2017 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2017.00100 Immunological evaluation of a novel HLA-A2 restricted phosphopeptide of tumor associated Antigen, TRAP1, on cancer therapy MH Lin, KY Shen, BS Liu, IH Chen, YP Sher , GC Tseng - Vaccine: X, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S259013621930018X Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2 M Derouazi, Y Wang, R Marlu, O Epaulard - Bioengineered , 2010 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/bbug.1.1.9482 Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization HW Chen, CH Leng, HY Liu, WF Cheng - Cancer Biology & , 2009 - Taylor & Francishttps://www.tandfonline.com/doi/pdf/10.4161/cbt.8.21.9732 protective against Toxoplasma gondii H Cong, EJ Mui, WH Witola, J Sidney - 2010 - immunome-research.biomedcentral https://immunome-research.biomedcentral.com/counter/pdf/10.1186/1745-7580-6-12.pdf Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of H Cong, EJ Mui, WH Witola, J Sidney , J Alexander - Immunome , 2010 - Springerhttps://link.springer.com/article/10.1186/1745-7580-6-12 based on chimeric peptides from different Leishmania infantum proteins induces dendritic cells maturation and promotes peptide-specific IFNγ-producing E Athanasiou, M Agallou , S Tastsoglou - Frontiers in , 2017 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2017.00684/full Epitope targeting with self-assembled peptide vaccines DF Zeigler , E Gage, R Roque, CH Clegg - npj Vaccines, 2019 - nature.comhttps://www.nature.com/articles/s41541-019-0125-5 Peptide and peptidomimetic-based vaccines A Singh , M Thakur - Peptide and Peptidomimetic Therapeutics, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B978012820141100008X

• Marke: Biosynth